154 related articles for article (PubMed ID: 26115958)
1. Magnetic resonance spectroscopy of paragangliomas: new insights into in vivo metabolomics.
Varoquaux A; le Fur Y; Imperiale A; Reyre A; Montava M; Fakhry N; Namer IJ; Moulin G; Pacak K; Guye M; Taïeb D
Endocr Relat Cancer; 2015 Aug; 22(4):M1-8. PubMed ID: 26115958
[TBL] [Abstract][Full Text] [Related]
2. Metabolome profiling by HRMAS NMR spectroscopy of pheochromocytomas and paragangliomas detects SDH deficiency: clinical and pathophysiological implications.
Imperiale A; Moussallieh FM; Roche P; Battini S; Cicek AE; Sebag F; Brunaud L; Barlier A; Elbayed K; Loundou A; Bachellier P; Goichot B; Stratakis CA; Pacak K; Namer IJ; Taïeb D
Neoplasia; 2015 Jan; 17(1):55-65. PubMed ID: 25622899
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Detection of Succinate by Magnetic Resonance Spectroscopy as a Hallmark of SDHx Mutations in Paraganglioma.
Lussey-Lepoutre C; Bellucci A; Morin A; Buffet A; Amar L; Janin M; Ottolenghi C; Zinzindohoué F; Autret G; Burnichon N; Robidel E; Banting B; Fontaine S; Cuenod CA; Benit P; Rustin P; Halimi P; Fournier L; Gimenez-Roqueplo AP; Favier J; Tavitian B
Clin Cancer Res; 2016 Mar; 22(5):1120-9. PubMed ID: 26490314
[TBL] [Abstract][Full Text] [Related]
4. A new specific succinate-glutamate metabolomic hallmark in SDHx-related paragangliomas.
Imperiale A; Moussallieh FM; Sebag F; Brunaud L; Barlier A; Elbayed K; Bachellier P; Goichot B; Pacak K; Namer IJ; Taïeb D
PLoS One; 2013; 8(11):e80539. PubMed ID: 24312232
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic Urine Profile: Searching for New Biomarkers of SDHx-Associated Pheochromocytomas and Paragangliomas.
Martins RG; Gonçalves LG; Cunha N; Bugalho MJ
J Clin Endocrinol Metab; 2019 Nov; 104(11):5467-5477. PubMed ID: 31504671
[TBL] [Abstract][Full Text] [Related]
6. SDHx mutation and pituitary adenoma: can in vivo 1H-MR spectroscopy unravel the link?
Branzoli F; Salgues B; Marjańska M; Laloi-Michelin M; Herman P; Le Collen L; Delemer B; Riancho J; Kuhn E; Jublanc C; Burnichon N; Amar L; Favier J; Gimenez-Roqueplo AP; Buffet A; Lussey-Lepoutre C
Endocr Relat Cancer; 2023 Feb; 30(2):. PubMed ID: 36449569
[TBL] [Abstract][Full Text] [Related]
7. Comparison of clinical and imaging features in succinate dehydrogenase-positive versus sporadic paragangliomas.
Venkatesan AM; Trivedi H; Adams KT; Kebebew E; Pacak K; Hughes MS
Surgery; 2011 Dec; 150(6):1186-93. PubMed ID: 22136839
[TBL] [Abstract][Full Text] [Related]
8. High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations.
Lima J; Feijão T; Ferreira da Silva A; Pereira-Castro I; Fernandez-Ballester G; Máximo V; Herrero A; Serrano L; Sobrinho-Simões M; Garcia-Rostan G
J Clin Endocrinol Metab; 2007 Dec; 92(12):4853-64. PubMed ID: 17848412
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR
Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and spectrum of SDHx mutations in pheochromocytoma and paraganglioma in patients from Belgium: an update.
Persu A; Lannoy N; Maiter D; Mendola A; Montigny P; Oriot P; Vinck W; Garin P; Hamoir M; Vikkula M
Horm Metab Res; 2012 May; 44(5):349-53. PubMed ID: 22566194
[TBL] [Abstract][Full Text] [Related]
11. Potential Pitfalls of SDH Immunohistochemical Detection in Paragangliomas and Phaeochromocytomas Harbouring Germline
Santi R; Rapizzi E; Canu L; Ercolino T; Baroni G; Fucci R; Costa G; Mannelli M; Nesi G
Anticancer Res; 2017 Feb; 37(2):805-812. PubMed ID: 28179334
[TBL] [Abstract][Full Text] [Related]
12. The mTORC1 Complex Is Significantly Overactivated in SDHX-Mutated Paragangliomas.
Oudijk L; Papathomas T; de Krijger R; Korpershoek E; Gimenez-Roqueplo AP; Favier J; Canu L; Mannelli M; Rapa I; Currás-Freixes M; Robledo M; Smid M; Papotti M; Volante M
Neuroendocrinology; 2017; 105(4):384-393. PubMed ID: 28122379
[TBL] [Abstract][Full Text] [Related]
13. Genotype-specific differences in the tumor metabolite profile of pheochromocytoma and paraganglioma using untargeted and targeted metabolomics.
Rao JU; Engelke UF; Sweep FC; Pacak K; Kusters B; Goudswaard AG; Hermus AR; Mensenkamp AR; Eisenhofer G; Qin N; Richter S; Kunst HP; Timmers HJ; Wevers RA
J Clin Endocrinol Metab; 2015 Feb; 100(2):E214-22. PubMed ID: 25459911
[TBL] [Abstract][Full Text] [Related]
14. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).
Gupta S; Zhang J; Milosevic D; Mills JR; Grebe SK; Smith SC; Erickson LA
Endocr Pathol; 2017 Sep; 28(3):253-268. PubMed ID: 28646318
[TBL] [Abstract][Full Text] [Related]
15. SDHC Promoter Methylation, a Novel Pathogenic Mechanism in Parasympathetic Paragangliomas.
Bernardo-Castiñeira C; Valdés N; Sierra MI; Sáenz-de-Santa-María I; Bayón GF; Perez RF; Fernández AF; Fraga MF; Astudillo A; Menéndez R; Fernández B; Del Olmo M; Suarez C; Chiara MD
J Clin Endocrinol Metab; 2018 Jan; 103(1):295-305. PubMed ID: 29126304
[TBL] [Abstract][Full Text] [Related]
16. Succinate dehydrogenase gene mutations in cardiac paragangliomas.
Martucci VL; Emaminia A; del Rivero J; Lechan RM; Magoon BT; Galia A; Fojo T; Leung S; Lorusso R; Jimenez C; Shulkin BL; Audibert JL; Adams KT; Rosing DR; Vaidya A; Dluhy RG; Horvath KA; Pacak K
Am J Cardiol; 2015 Jun; 115(12):1753-9. PubMed ID: 25896150
[TBL] [Abstract][Full Text] [Related]
17. Metabolomics in the Diagnosis of Pheochromocytoma and Paraganglioma.
Dwight T; Kim E; Novos T; Clifton-Bligh RJ
Horm Metab Res; 2019 Jul; 51(7):443-450. PubMed ID: 31307108
[TBL] [Abstract][Full Text] [Related]
18. Head and neck paragangliomas: Report of 175 patients (1989-2010).
Papaspyrou K; Mewes T; Rossmann H; Fottner C; Schneider-Raetzke B; Bartsch O; Schreckenberger M; Lackner KJ; Amedee RG; Mann WJ
Head Neck; 2012 May; 34(5):632-7. PubMed ID: 21692132
[TBL] [Abstract][Full Text] [Related]
19. Translating
Casey RT; McLean MA; Madhu B; Challis BG; Ten Hoopen R; Roberts T; Clark GR; Pittfield D; Simpson HL; Bulusu VR; Allinson K; Happerfield L; Park SM; Marker A; Giger O; Maher ER; Gallagher FA
JCO Precis Oncol; 2018 Mar; 2():1-12. PubMed ID: 30949620
[TBL] [Abstract][Full Text] [Related]
20. Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators.
Gimenez-Roqueplo AP; Caumont-Prim A; Houzard C; Hignette C; Hernigou A; Halimi P; Niccoli P; Leboulleux S; Amar L; Borson-Chazot F; Cardot-Bauters C; Delemer B; Chabolle F; Coupier I; Libé R; Peitzsch M; Peyrard S; Tenenbaum F; Plouin PF; Chatellier G; Rohmer V
J Clin Endocrinol Metab; 2013 Jan; 98(1):E162-73. PubMed ID: 23162105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]